Neurocrine Biosciences Inc (NBIX) Earnings

NBIX Earnings Reports

Positive Surprise Ratio

NBIX beat 18 of 42 last estimates.

43%

Next Report

Next Week

Date of Next Report

Nov 02, 2026

Estimate for Q3 26 (Revenue/ EPS)

$1.07B

$1.97

Implied change from Q2 26 (Revenue/ EPS)

+11.10%

+41.73%

Implied change from Q3 25 (Revenue/ EPS)

+34.04%

-3.43%

Neurocrine Biosciences Inc earnings per share and revenue

On Jul 30, 2026, NBIX reported earnings of 1.39 USD per share (EPS) for Q2 26, beating the estimate of 1.36 USD, resulting in a 1.52% surprise. Revenue reached 959.00 million, compared to an expected 903.51 million, with a 6.14% difference. The market reacted with a -10.08% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 18 analysts forecast an EPS of 1.97 USD, with revenue projected to reach 1.07 billion USD, implying an increase of 41.73% EPS, and increase of 11.10% in Revenue from the last quarter.

FAQ

What were Neurocrine Biosciences Inc's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Neurocrine Biosciences Inc reported EPS of $1.39, beating estimates by 1.52%, and revenue of $959.00M, 6.14% above expectations.

How did the market react to Neurocrine Biosciences Inc's Q2 2026 earnings?

The stock price moved down -10.08%, changed from $185.50 before the earnings release to $166.80 the day after.

When is Neurocrine Biosciences Inc expected to report next?

The next earning report is scheduled for Nov 02, 2026.

What are the forecasts for Neurocrine Biosciences Inc's next earnings report?

Based on 18 analysts, Neurocrine Biosciences Inc is expected to report EPS of $1.97 and revenue of $1.07B for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.